Search Results for: carcinoid syndrome

Patient Education on Carcinoid Syndrome from Diagnosis to Treatment

Recorded live on March 1, 2017, this one-hour program — with NET specialist Dr. Edward Wolin, Grace Goldstein of Carcinoid Cancer Foundation, and a panel of patients — provides in-depth education on carcinoid syndrome. Read our blog for more detail or…

Breaking News on Rare Disease Day — FDA Approves New Drug for Carcinoid Syndrome Diarrhea

On February 28, 2017, the US Food and Drug Administration (FDA) approved XERMELO™ (telotristat ethyl) 250 mg as a first and only orally administered therapy for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (SSA)…

Live, Online Event – Patient Education Program on Carcinoid Syndrome

Cancer Coach Live, in partnership with the Carcinoid Cancer Foundation, is presenting a special patient education live event on Carcinoid Syndrome: From Diagnosis to Treatment on Wednesday, March 1 from 11 am to 12 noon EST.  Whether you are a newly diagnosed…

Patient Education on Carcinoid Syndrome: From Diagnosis to Treatment

A Live Online Event on Wednesday, March 1, 11 am to 12 noon Eastern Standard Time

Ask Your Questions during the Live Program or Submit Them in Advance

Cancer Coach Live, in partnership with the Carcinoid Cancer Foundation, is presenting a special patient…

Speaking Up: What Stands in the Way of Patient-Physician Conversation about Neuroendocrine Tumors and Carcinoid Syndrome

Members of the neuroendocrine tumor (NET) community are invited to attend an informal discussion, hosted by Lexicon Pharmaceuticals, about the barriers and opportunities in discussing NETs and carcinoid syndrome with your healthcare professional…

Carcinoid Syndrome Impact Survey Results to Be Presented During September 21 Webcast

Members of the carcinoid and neuroendocrine tumor community are invited to be the first to hear the results of the Carcinoid Syndrome Impact Survey that was conducted this summer.  A Webcast about the survey results will be presented on Wednesday, September…

Seeking Carcinoid Syndrome Patients for New Publication

Carcinoid Syndrome Patients: Share Your Journey  — Can you help us to raise awareness about carcinoid syndrome?

Health Monitor Network, in collaboration with the Carcinoid Cancer Foundation, is producing a Guide to Living with Carcinoid Syndrome…

New Survey for the Carcinoid Syndrome Community

Dear Friends,

We are excited to invite you to participate in the new Carcinoid Syndrome Impact Survey, which is designed to help better understand the impact that carcinoid syndrome has on patients’ lives, while also exploring physicians’ treatment…

FDA Priority Review of Lexicon’s New Drug Application for Telotristat Etiprate Treatment for Carcinoid Syndrome

Lexicon Pharmaceuticals announced on May 31, 2016 that the U.S. Food and Drug Administration has accepted for filing the New Drug Application for telotristat etiprate, an oral drug for the treatment of CARCINOID SYNDROME. “The FDA has granted…

Carcinoid Tumors and the Carcinoid Syndrome: What’s new in the therapeutic pipeline

Presented by
Larry K. Kvols MD
Professor of Medicine
H. Lee Moffitt Cancer Center & Research Institute
Tampa, FL

Carcinoid Symposium 2002
Tampa, Florida
April 12-13, 2002

Dianne Comstock:

Our first speaker of the day is Dr. Larry Kvols who is accompanied…